This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: The Hospital for Sick Children. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Jeff Biernaskie: Innovator in Skin-Derived Precursor Cell Technology
Introduction
Jeff Biernaskie is a notable inventor based in Toronto, Canada. He has made significant contributions to the field of regenerative medicine, particularly in the area of hair follicle formation. His innovative work has the potential to impact treatments for hair loss and skin regeneration.
Latest Patents
Biernaskie's most recent patent is titled "Skin-derived precursor cells and uses thereof." This invention features methods of inducing hair follicle formation in mammals through the transplantation of skin-derived precursors (SKPs) and keratinocytes into the skin. The patent also includes compositions and kits that utilize SKPs and keratinocytes. Additionally, it outlines methods for producing dermal sheets from SKPs and the applications of such sheets in medical treatments.
Career Highlights
Throughout his career, Jeff Biernaskie has worked at prestigious institutions, including The Hospital for Sick Children and The Hospital for Sick Children Research Institute. His work in these organizations has allowed him to collaborate with leading experts in the field of pediatric medicine and research.
Collaborations
Biernaskie has collaborated with notable colleagues, including Freda Diane Miller and Freda D Miller. These partnerships have contributed to the advancement of research in skin-derived precursor cells and their applications.
Conclusion
Jeff Biernaskie's innovative work in skin-derived precursor cell technology showcases his commitment to advancing regenerative medicine. His contributions have the potential to transform treatments for hair loss and skin regeneration, making him a significant figure in the field.